GLSI
Greenwich LifeSciences, Inc.
23.57
1 x 17.16
2 x 30.32
bid
ask
-
0.13
0.55%
10:16 AM
timesize
| Ytd | 12.18% | |
| 1y | 138.56% |
23.45
day range
23.95
7.85
52 week range
33.56
| Open | 23.69 | Prev Close | 23.70 | Low | 23.45 | High | 23.95 | Mkt Cap | 345.97M |
| Vol | 15.70K | Avg Vol | 143.32K | EPS | -1.61 | P/E | N/A | Forward P/E | -14.83 |
| Beta | 3.32 | Short Ratio | 21.41 | Inst. Own | 8.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 24.15 | 200-d Avg | 19.64 | 1yr Est | 38.00 |
| Income Statement | |||
| Operating Expenses | 5.73M | ||
| Research and Development Expense | 5.21M | ||
| Selling, General and Administrative Expense | 518.19K | ||
| Operating Income | -5.73M | ||
| Net Income | -5.66M | ||
| Net Income Common Stock | -5.66M | ||
| Net Income Common Stock (USD) | -5.66M | ||
| Consolidated Income | -5.66M | ||
| Earnings per Basic Share | -0.39 | ||
| Earnings per Basic Share (USD) | -0.39 | ||
| Earnings per Diluted Share | -0.39 | ||
| Earning Before Interest & Taxes (EBIT) | -5.66M | ||
| Earning Before Interest & Taxes (USD) | -5.66M | ||
| Weighted Average Shares | 14.57M | ||
| Weighted Average Shares Diluted | 14.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.51M | ||
| Cash and Equivalents (USD) | 10.51M | ||
| Current Assets | 10.51M | ||
| Total Assets | 10.51M | ||
| Current Liabilities | 5.24M | ||
| Total Liabilities | 5.24M | ||
| Accumulated Retained Earnings (Deficit) | -92.79M | ||
| Shareholders Equity | 5.27M | ||
| Shareholders Equity (USD) | 5.27M | ||
| Trade and Non-Trade Payables | 4.51M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 9.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.33M | ||
| Issuance (Purchase) of Equity Shares | 9.03M | ||
| Net Cash Flow from Operations | -4.70M | ||
| Share Based Compensation | 1.54M | ||